Curcumin causes death of cancer cells
Many components of the drugs, used by modern medicine, were once isolated from plants. For example, aspirin was originally derived from willow and in 1899 was sold by the German company "Bayer" as a drug under the "Aspirin" trademark. Paclitaxel - a drug for cancer chemotherapy - was isolated in 1962 from the yew as a result of studies conducted by the National Institute of Oncology United States. Artemisinin, widely used to treat malaria and has saved millions of lives, was synthesized from wormwood in 1972, for which the author was awarded the Nobel Prize in 2015.
In recent decades, the biologically active substance curcumin is attracting the attention of scientists around the world because of its obvious therapeutic properties. In 1949 for the first time it has been scientifically proven antibacterial properties of curcumin, but antibiotics cope with this task quickly - as a result of curcumin unjustly forgotten for decades. But around the mid 80-ies began to appear, new research reveals more and more new and totally unexpected properties of curcumin.
It turned out that it has not only bacterial, but also anti-inflammatory, antioxidant, anesthetic properties. More importantly - curcumin is able to activate the body's defense mechanisms of cells, making them resistant to stress. Studies have also shown that it causes the death of cancer cells. Although curcumin does not cure the cancer, its properties are actively exploring in order to use as an important aid, which can be used in combination with other drugs for the treatment of cancer.
Moreover, curcumin works as geroprotector, preventing the aging process. One of the main causes of aging is the appearance of DNA mutations in the cells. Such cells are no longer able to perform their normal functions, and the number of mutations in them only continues to grow. This in turn leads to a deterioration of the internal organs, consisting of cells. Curcumin, once in the cell with more mutations, causing their death, and slows down the aging process. Over time, the place occupied by the mutated cells healthy.
With the formation of an understanding of what a curcumin, scientists have begun to actively develop a variety of products based on it. But a kind of stumbling block remained low bioavailability of curcumin molecules. The fact that the pill with curcumin from the intestine into the blood penetrate only a small portion of the substance. And that still enters the bloodstream quickly neutralize liver enzymes - and excreted from the body. As a result, curcumin molecules do not reach the majority of cells. Thus, the main therapeutic effects are exerted only on the intestines, and the beneficial effects on other cells of the body has been very limited and almost not felt by people taking it. The main problem facing the experts, it was delivery of curcumin molecules in cells. The introduction of the substance in the blood and could not solve the problem - curcumin is very poorly soluble in liquid.
Scientists were able to solve the problem of transportation of curcumin - Research Laboratory, which is part of the corporation Sabinsa, has developed a unique formula, made up, in addition to curcumin, including two of its chemical derivatives (dimetoksikurkumin and bisdimetoksikurkumin), as well as a patented laboratory component - Bioperine. It is natural and safe for the body and is able to temporarily neutralize the effect of liver enzymes, preventing the removal of curcumin from the body.
Thus, entering the body part of the formula, curcumin molecules have time to provide a therapeutic effect. The therapeutic effect was studied in more than 80 publications. Furthermore, as a result of 45 clinical trials, it was confirmed that the drug prevents the development of metabolic syndrome (obesity), relieves symptoms in diabetes of the second type and reduces the likelihood of complications, normalizes cholesterol, slow the progression of atherosclerosis, relieves symptoms of psoriasis, arthritis (in some cases may even cure it), it reduces the likelihood of the development of neurodegenerative diseases and is able to slow the progression of Alzheimer's disease.
In recent decades, the biologically active substance curcumin is attracting the attention of scientists around the world because of its obvious therapeutic properties. In 1949 for the first time it has been scientifically proven antibacterial properties of curcumin, but antibiotics cope with this task quickly - as a result of curcumin unjustly forgotten for decades. But around the mid 80-ies began to appear, new research reveals more and more new and totally unexpected properties of curcumin.
It turned out that it has not only bacterial, but also anti-inflammatory, antioxidant, anesthetic properties. More importantly - curcumin is able to activate the body's defense mechanisms of cells, making them resistant to stress. Studies have also shown that it causes the death of cancer cells. Although curcumin does not cure the cancer, its properties are actively exploring in order to use as an important aid, which can be used in combination with other drugs for the treatment of cancer.
Moreover, curcumin works as geroprotector, preventing the aging process. One of the main causes of aging is the appearance of DNA mutations in the cells. Such cells are no longer able to perform their normal functions, and the number of mutations in them only continues to grow. This in turn leads to a deterioration of the internal organs, consisting of cells. Curcumin, once in the cell with more mutations, causing their death, and slows down the aging process. Over time, the place occupied by the mutated cells healthy.
With the formation of an understanding of what a curcumin, scientists have begun to actively develop a variety of products based on it. But a kind of stumbling block remained low bioavailability of curcumin molecules. The fact that the pill with curcumin from the intestine into the blood penetrate only a small portion of the substance. And that still enters the bloodstream quickly neutralize liver enzymes - and excreted from the body. As a result, curcumin molecules do not reach the majority of cells. Thus, the main therapeutic effects are exerted only on the intestines, and the beneficial effects on other cells of the body has been very limited and almost not felt by people taking it. The main problem facing the experts, it was delivery of curcumin molecules in cells. The introduction of the substance in the blood and could not solve the problem - curcumin is very poorly soluble in liquid.
Scientists were able to solve the problem of transportation of curcumin - Research Laboratory, which is part of the corporation Sabinsa, has developed a unique formula, made up, in addition to curcumin, including two of its chemical derivatives (dimetoksikurkumin and bisdimetoksikurkumin), as well as a patented laboratory component - Bioperine. It is natural and safe for the body and is able to temporarily neutralize the effect of liver enzymes, preventing the removal of curcumin from the body.
Thus, entering the body part of the formula, curcumin molecules have time to provide a therapeutic effect. The therapeutic effect was studied in more than 80 publications. Furthermore, as a result of 45 clinical trials, it was confirmed that the drug prevents the development of metabolic syndrome (obesity), relieves symptoms in diabetes of the second type and reduces the likelihood of complications, normalizes cholesterol, slow the progression of atherosclerosis, relieves symptoms of psoriasis, arthritis (in some cases may even cure it), it reduces the likelihood of the development of neurodegenerative diseases and is able to slow the progression of Alzheimer's disease.